Papers - MORI KAZUYUKI
-
I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling
Mikami J, Tobisawa Y, Yoneyama T, Hatakeyama S, Mori K, Hashimoto Y, Koie T, Ohyama C, Fukuda M：
Cancer Sci 2015.12
-
Detection of Core2 β-1, 6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer
Kojima Y, Yoneyama T, Hatakeyama S, Mikami J, Sato T, Mori K, Hashimoto Y, Koie T, Ohyama C, Fukuda M, Tobisawa Y
PLoS One 2015.9
-
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
Koie T, Ohyama C, Hosogoe S, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K
Case Rep Urol 2015.6
-
Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.
Koie T, Ohyama C, Yoneyama T, Yamamoto H, Imai A, Hatakeyama S, Hashimoto Y, Yoneyama T, Tobisawa Y, Mori K
BMC Urol 15 ( 1 ) 32 2015.4
-
Nanoparticle BCG
Kazuyuki Mori
Jpn J Urol Surg 28 ( 2 ) 151 - 154 2015.2
-
Measurement of aberrant glycosylation of prostate specific antigen can improve specificity in early detection of prostate cancer.（共著）
Yoneyama T, Ohyama C, Hatakeyama S, Narita S, Habuchi T, Koie T, Mori K, Hidari KI, Yamaguchi M, Suzuki T, Tobisawa Y
Biochem Biophys Res Commun 448 ( 4 ) 390 - 396 2014.6
-
Outcome Comparison of ABO-Incompatible Kidney Transplantation WithLow-DoseRituximab andABO-CompatibleKidneyTransplantation:A Single-Center Experience.（共著）
1. Hatakeyama S, Fujita T, Murakami R, Suzuki Y, Sugiyama N, Yamamoto H, Okamoto A, Imai A, Tobisawa Y, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Ohyama C
Transplantation Proceedings 46 ( 2 ) 445 - 448 2014.3
-
Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.（共著）
Okamoto T, Yoneyama MS, Hatakeyama S, Mori K, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Fukuda M, Ohyama C, Tsuboi S.
Mol Med Rep 7 ( 2 ) 359 - 64 2013.2
-
Kidney Transplantation at Hirosaki kidney transplant unit-initial 5year experience.（共著）
Narumi S, Murakami R, Hatakeyama S, Fujita T, Koie T, Yoneyama T, Kudoh S, Ksmimura N, Mori K, Shimada M, Nakamura N, Umehara M, Saitoh H, Okumura K, Hakamada K, Ohyama C
Hirosaki Medical Journal 63 ( 2-4 ) 136 - 142 2012.12
-
MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis. （共著）
Suzuki Y, Sutoh M, Hatakeyama S, Mori K, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Habuchi T, Arai Y, Fukuda M, Ohyama C, Tsuboi S.
Int J Oncol 40 ( 6 ) 1831 - 1838 2012.7
-
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans （共著）
Tsuboi S, Sutoh M, Hatakeyama S, Hiraoka N, Habuchi T, Horikawa Y, Hashimoto Y, Yoneyama T, Mori K, Koie T, Nakamura T, Saitoh H, Yamaya K, Funyu T, Fukuda M, Ohyama C.
EMBO J 30 ( 15 ) 3173 - 3185 2011.7
-
膀胱癌における尿テロメラーゼ活性簡易測定法の有用性
岩渕 郁哉, 盛 和行他
泌尿器科紀要 56 ( 10 ) 551 - 557 2010.10
-
Role of peroxynitrite and recombinant human manganese superoxide dismutase in reducing ischemia-reperfusion renal tissue injury
Rahman NA, Mori K, Mizukami M, Suzuki T, Takahashi N, Ohyama C
Transplantation Proceedings 41 3603 - 3610 2009.11
-
Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.（共著）
Okamoto A, Yamamoto H, Imai A, Hatakeyama S, Iwabuchi I, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Mori K, Yamaya K, Ohyama C.
Oncol Rep 21 ( 1 ) 73 - 79 2009.1
-
Low-dose instillation therapy with bacille Calmette-Guérin Tokyo 172 strain after transurethral resection: historical cohort study（共著）
Yoneyama T, Ohyama C, Imai A, Ishimura H, Hagisawa S, Iwabuchi I, Mori K, Kamimura N, Koie T, Yamato T, Suzuki T.
Urology 71 ( 6 ) 1161 - 1165 2008.6
-
Short-term outcome of neoadjuvant gemcitabine-carboplatin therapy for muscle-invasive bladder cancer"jointly worked"
Yamato T, Okamoto A, Imai A, Ishimura D, Hatakeyama S, Hagisawa S, Iwabuchi I, Yoneyama T, Mori K, Koie T, Ohyama C.
Gan To Kagaku Ryoho 35 ( 1 ) 83 - 86 2008.1
-
前立腺癌—基礎・臨床研究のアップデートーII.臨床研究 診断 病期診断 臨床病期分類（共著）
大山 力,古家 琢也,盛 和行
日本臨床 65 ( Suppl10 ) 285 - 288 2007.12
-
INVESTIGATION OF ACTIVE BACILLUS CALMETTE-GUÉRIN (BCG) COMPONENT ON BLADDER CANCER CELL LINE(jointly worked)
Yoshikawa K et al
Hirosaki Med J 59 ( 1 ) 41 - 48 2007.11
-
被膜下前立腺摘除術（共著）
大山 力,大和 隆,米山 高弘,古家 琢也,盛 和行
臨床泌尿器科 61 ( 11 ) 883 - 888 2007.10
-
尿路として利用された腸管の発癌性について（共著）
大山 力,米山 高弘,神村 典孝,大和 隆,古家 琢也,萩沢 茂,岩渕 郁哉,盛 和行
Urology View 5 ( 3 ) 86 - 91 2007.6